Paidion Research

Certara, Paidion Research partner on pediatric drug development

Friday, September 11, 2015

Certara, a global biosimulation technology-enabled drug development company, and Paidion Research, a Durham, N.C.-based pediatric CRO, have partnered to promote more efficient and reliable drug development for pediatric patients. The partnership harnesses Certara’s biosimulation (modeling and simulation) and regulatory writing capabilities with Paidion’s regulatory strategy and pediatric clinical trial management expertise to address the critical challenges of bringing new therapies to children.

[Read More]

Paidion Research, a new pediatric CRO, launches

Wednesday, March 25, 2015

Paidion Research, a new CRO focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently opened for business. Headquartered in Durham, N.C., Paidion combines pediatric clinical pharmacology experience with innovative pediatric regulatory strategies and trial methodologies to provide best-in-class service to drug and device development partners in industry, government, academia and nonprofits.

[Read More]